Jill Macoska

16PUBLICATIONS
34CO-AUTHORS
Genome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 09, 2026
Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer.

|Mar 21, 2025
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells.

Maryam Labaf, Wanting Han, Songqi Zhang

|Jun 08, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

Zifeng Wang, Scott L Townley, Songqi Zhang

|Dec 14, 2023
A Bayesian noisy logic model for inference of transcription factor activity from single cell and bulk transcriptomic data.

Argenis Arriojas, Susan Patalano, Jill Macoska

|Sep 04, 2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.

Anna Besschetnova, Wanting Han, Mingyu Liu

|Aug 07, 2023
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.

Zifeng Wang, Jessica Petricca, Mingyu Liu

Pageof 3

Frequent Collaborators

8 joint publications

Changmeng Cai

8 joint publications

Dong Han

5 joint publications

Wanting Han

5 joint publications

Housheng Hansen He